User profiles for Madiha Hashmi
 | Madiha HashmiZiauddin University Verified email at zu.edu.pk Cited by 3589 |
A living WHO guideline on drugs for covid-19
This living guideline by Arnav Agarwal and colleagues (BMJ 2020; 370: m3379, doi: 10.1136/bmj.
m3379) was last updated on 22 April 2022, but the infographic contained two dosing …
m3379) was last updated on 22 April 2022, but the infographic contained two dosing …
A living WHO guideline on drugs for covid-19
…, P Gee, M Haider, M Gotte, N Harley, M Hashmi… - bmj, 2020 - bmj.com
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …
earlier versions (available as data supplements). New recommendations will be published as …
Critical care bed capacity in Asian countries and regions
…, KK Sann, BR Shrestha, M Hashmi… - Critical care …, 2020 - journals.lww.com
Objective: To assess the number of adult critical care beds in Asian countries and regions in
relation to population size. Design: Cross-sectional observational study. Setting: Twenty-…
relation to population size. Design: Cross-sectional observational study. Setting: Twenty-…
Medical masks versus N95 respirators for preventing COVID-19 among health care workers: a randomized trial
Background: It is uncertain if medical masks offer similar protection against COVID-19 compared
with N95 respirators. Objective: To determine whether medical masks are noninferior to …
with N95 respirators. Objective: To determine whether medical masks are noninferior to …
The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control
Tuberculosis (TB) is one of the top ten causes of death worldwide. In 2016, there were 490,000
cases of multi-drug resistant TB globally. Over 2 billion people have asymptomatic latent …
cases of multi-drug resistant TB globally. Over 2 billion people have asymptomatic latent …
Corticosteroid therapy for sepsis: a clinical practice guideline
Do corticosteroids reduce death or improve recovery in people with sepsis or septic shock?
Our panel make a weak recommendation to give corticosteroids to people with all types and …
Our panel make a weak recommendation to give corticosteroids to people with all types and …
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Background We describe demographic features, treatments and clinical outcomes in the
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) COVID-19 …
International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) COVID-19 …
[HTML][HTML] The story of critical care in Asia: a narrative review
…, MB Mat-Nor, GS Shrestha, M Hashmi… - Journal of intensive …, 2021 - Springer
Background Asia has more critically ill people than any other part of our planet. The aim of
this article is to review the development of critical care as a specialty, critical care societies …
this article is to review the development of critical care as a specialty, critical care societies …
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
Introduction Very little is known about possible clinical sequelae that may persist after
resolution of acute COVID-19. A recent longitudinal cohort from Italy including 143 patients …
resolution of acute COVID-19. A recent longitudinal cohort from Italy including 143 patients …
[HTML][HTML] The utility of neutrophil gelatinase-associated Lipocalin (NGAL) as a marker of acute kidney injury (AKI) in critically ill patients
In current clinical practice, Serum Creatinine (SCr) is a commonly used marker for the diagnosis
of acute kidney injury (AKI). Unfortunately, due to a delayed increase in SCr, it is unable …
of acute kidney injury (AKI). Unfortunately, due to a delayed increase in SCr, it is unable …